What the English source shows.
- Evidence group
- Blinded human studies
- Journal
- ELECTRONIC JOURNAL OF METABOLISM & NUTRITION OF CANCER (6)3: 346-350, 2019
- English PDF
- Page 21
Abstract focus
Objective To explore the effect of ABD Bioactives on myelosuppression alleviation in lung cancer patients during chemotherapy. Methods 44 lung cancer patients who received chemotherapywererandomlydividedintoanintervention group and a control group.
Context from Dr. Gutman’s comments
This human study was performed in lung cancer patients. 44 patients were randomly divided into control (standard treatment) or intervention (Immunocal added) groups.
How to use this study responsibly
- Read it according to its evidence group, not as a universal product promise.
- Use the English PDF to verify the abstract and commentary directly.
- For medical conditions, treatment, pregnancy, breastfeeding or medication, speak with a qualified healthcare professional.